ON DEMAND R AND D DATA PLATFORM GSK FINAL2
>>Hey, everyone, Thanks for taking them to join the story. Hope you and your loved ones are safe during these tough times. Let me start by introducing myself. My name is Michelle. When I walk for GlaxoSmithKline, GSK as an engineering manager in my current role, A little protocol platform A P s, which is part of the already data platform here in G S, K R and D Tech. I live in Dallas, Texas. I have a Masters degree in computer science on a bachelor's in electronics and communication engineering. I started my career as a software developer on over these years again a lot of experience in leading and building, not scale and predicts products and solutions. I also have a complete accountability for container platforms here at GSK or any tick. I've been working very closely with Dr Enterprise, which is no Miranda's for more than three years to enable container platforms that yes, came on mainly in our own Itek. So that's me. Let >>me give you a quick overview on agenda for today's talk. I'll start with what we do here at GSK on what is RND data platform. Then I'll give you an overview on What are the business drivers that >>motivated US toe? Take this container Germany on some insight into learnings on accomplishments over these years. Working with Dr Enterprise on the container platforms Lately, you must have seen a lot of articles off there which talk about how ts case liberating technologies like artificial intelligence, mission learning, UN data and analytics for the Douglas Corey process. I'm very excited to see the progress we have made in technology, but what makes us truly unique is our commitment to the patient. >>We're G escape, help millions of people, do more, feel better and live longer. Wear a global company that is focused on three were tickles pharmaceuticals vaccines on consumer healthcare. Our main intent is to lower the >>burden on the impact of diseases on the patients. Here at GSK, we allow science to drive the technology. This helps us toe build innovative products. That's helps our scientists to make better and faster additions throughout the drug discovery by plane. >>With that, let me give you some >>context on what currently data platform is how it is enabled. A T escape started in mid 2016. What used to be called us are any information platform whose main focus was to centralize curate on rationalized all the data produced within the others are in the business systems in orderto drive, a strategic business value, standardization of clinical trials, Genome Wide Association Study Analysis, also known as Jesus Storage and Crossing Off Rheal. World Evidence data some of the examples off how the only platform was used to deliver the business value four years later. No, a new set off business rivals of changing our landscape. The irony Information Platform is evolving to be a hybrid, multi cloud solution and is known as already did a platform refering to 20 >>19 GSK's annual report. These are the four teams that there are any platform will be mainly focused on. We're expanding our data capabilities to support the use. Escape by a former company on evolving into a hybrid medical platform is one of the many steps that we're taking to be future ready. Our key focus will still be making >>greater recommendations better and faster by using that wants us. We're making the areas like artificial intelligence and machine learning. No doc brings us toe. What is Germany is important. Why are we taking this German with that? Let me take you to the next topic off. Like the process of discovery, Francisco is not an easy process. Talking about the recent events occurred over the last few months on the way. How all our lives are impacted. It is a lot of talk on information going about. Why did drug discovery process is so tough working for a global health care company? I get asked this question very frequently. From many people I interact with. Question is like, Why is that? This car is so tough on why it takes so much time. Drug discovery is a complex process that involves multiple different stages on at each and every stage. There is huge amounts of data that the scientists have took process to make some decisions. Studies have shown that only 3% off small molecules entering the human studies actually become medicines. If you're new to drug discovery, you may ask, like what is the targets? Targets so low? We humans are very complex species, >>not going into the details of the process. We're G escape >>have made a lot of investments into technology that enabled us to make data river conditions. Throw the drug Discovery pipeline >>as we implement. As we started implementing these tools and technologies to enable already did a platform, we started to get a better appreciation off how these tools in track on integrate >>with each other. Our goal wants to make this platform a jail, the platform that can work at scale so that we can provide a great user experience and contribute back to the bread discovery pipeline so that the scientists can make faster editions. We want our ardently users to consume the data, and the service is available on the platform seamlessly in a self service fashion. And we also have to accomplish this by establishing trust. And then we have to end also enable the academic partnerships, acquisitions, collaborations that DSK has, which actually brings a lot of data on value to our scientists. So when we talk about so many collaborations and a lot of these systems, what this brings in is wide range off systems and platforms that are fundamentally built on different infrastructure. This is where Doctor comes into fiction on our containers significance. >>We have realized the power of containers on how we can simplify this complex ecosystem by using containers and provide a faster access off data to war scientists who didn't go >>back and contribute back to the drug discovery by play. >>With that, let me take talk to you about >>the containers journey and she escaped. So we started our container journey in late 2017. We started working with Dr Enterprise to enable the container platform. This is on our on prem infrastructure Back then, or first year or so we walked through multiple Pelosis did a lot of testing to make sure our platform is stable before we onboard either the data or the user applications. I was part of this complete journey on Dr Stream has worked with us very closely towards you. The first milestone off establishing a stable container platform. A tsk. Now, getting into 2019 we started deploying our applications in production environment. I cannot go into the details of what this Absar, but they do include both data pipelines as well as Web services. You know, initial days we have worked a lot on swamp, but in 2019 is when we started looking into communities in the same year, we enable kubernetes orchestration on the doctor and replace platform here at GSK and also made it as a de facto orchestra coming into 2020. All our micro service applications are undead. A pipelines are migrated to the container platforms on all of these are orchestrated by Cuban additional on these air applications that are running in production. As of today, we have made the container forced approach as an architectural standard across already taking GSK. We also started deploying our AML training models onto containers on All this work is happening on our Doctor Enterprise platform. Also as part off are currently platforms hybrid multicolored journey. We started enabling container and kubernetes based platforms on public clubs. Now going into 2021 on future. Enabling our RND users to easily access data and applications in a platform agnostic way is very crucial for our success because previously we had only onto him. Now we have public clothes that are getting involved on One of >>the many steps we're taking through this journey is to >>watch allies the data on ship data and containers or kubernetes volumes on demand to our our end users of scientists. And this allows us to deliver data to our scientists wherever they want in a very security on. We're leveraging doctor to do it. So that's >>our future. Learning on with that, let's take a deep dive into fuel for >>our accomplishments over these years. I want to start with a general demand and innovative one very interesting use case that we developed on Dr. This is a rapid prototyping capability that enabled our scientists seamlessly to Monday cluster communication. This was one off the biggest challenges which way his face for a long time and with the help of containers, were able to solve this on provide this as a capability to our scientists. We actually have shockers this capability in one of the doctor conferences before next. As I've said before, by migrating all over web services into containers, we not only achieved horizontal scalability for those specific services, but also saved more than 50% in support costs for the applications which we have migrated by making Docker image as an immutable artifact In our bill process, we are now able to deploy our APS or models in any container or Cuban, its base platform, either in on Prem or in a public club. We also made significant improvements towards the process. A not a mission By leveraging docker containers, containers have played a significant role in keeping US platform agnostic and thus enabling our hybrid multi cloud Germany valuable for out already did scientists. As I mentioned before, data virtualization is another viewpoint we have in terms off our next steps off where we want to take kubernetes on where we wanna leverage open it. Us. What you see here are just a few off many accomplishments which we have our, um, achieved by using containers for the past three years or so. So with that before I close all the time and acknowledge all our internal partners who has contributed a lot to this journey mainly are in the business are on the deck on the broader take. Organizations that escape also want to time document present Miranda's for being such a great partner throughout this journey and also giving us an opportunity to share this success story today. Lastly, thanks for everyone to listening to the stop and please feel free to reach out. If you have any questions or suggestions, let's be fit safe. Thank you
SUMMARY :
Hey, everyone, Thanks for taking them to join the story. What are the business drivers that our commitment to the patient. Our main intent is to lower the burden on the impact of diseases on the patients. World Evidence data some of the examples off how the only platform was evolving into a hybrid medical platform is one of the many steps that we're taking to be There is huge amounts of data that the scientists have took process to not going into the details of the process. have made a lot of investments into technology that enabled us to make data river conditions. enable already did a platform, we started to get a better appreciation off how these And then we have to end also enable the academic partnerships, I cannot go into the details of what this Absar, but they do include both data pipelines We're leveraging doctor to do it. Learning on with that, let's making Docker image as an immutable artifact In our bill process, we are now able to
SENTIMENT ANALYSIS :
ENTITIES
Entity | Category | Confidence |
---|---|---|
DSK | ORGANIZATION | 0.99+ |
Michelle | PERSON | 0.99+ |
2019 | DATE | 0.99+ |
2020 | DATE | 0.99+ |
GSK | ORGANIZATION | 0.99+ |
late 2017 | DATE | 0.99+ |
2021 | DATE | 0.99+ |
G S | ORGANIZATION | 0.99+ |
three | QUANTITY | 0.99+ |
mid 2016 | DATE | 0.99+ |
K R | ORGANIZATION | 0.99+ |
Monday | DATE | 0.99+ |
more than 50% | QUANTITY | 0.99+ |
D Tech | ORGANIZATION | 0.99+ |
Dallas, Texas | LOCATION | 0.99+ |
four teams | QUANTITY | 0.99+ |
more than three years | QUANTITY | 0.98+ |
GlaxoSmithKline | ORGANIZATION | 0.98+ |
four years later | DATE | 0.98+ |
US | LOCATION | 0.98+ |
today | DATE | 0.98+ |
first milestone | QUANTITY | 0.98+ |
Dr Stream | ORGANIZATION | 0.97+ |
millions of people | QUANTITY | 0.97+ |
3% | QUANTITY | 0.97+ |
one | QUANTITY | 0.96+ |
Miranda | PERSON | 0.95+ |
Germany | LOCATION | 0.94+ |
20 | QUANTITY | 0.94+ |
Itek | ORGANIZATION | 0.93+ |
both data pipelines | QUANTITY | 0.92+ |
Dr Enterprise | ORGANIZATION | 0.92+ |
Francisco | PERSON | 0.88+ |
Miranda | ORGANIZATION | 0.84+ |
each | QUANTITY | 0.82+ |
Cuban | OTHER | 0.82+ |
G escape | ORGANIZATION | 0.78+ |
first year | QUANTITY | 0.75+ |
One | QUANTITY | 0.74+ |
last | DATE | 0.72+ |
past three years | DATE | 0.71+ |
months | DATE | 0.7+ |
Crossing Off Rheal | TITLE | 0.68+ |
GSK | TITLE | 0.67+ |
German | OTHER | 0.65+ |
Douglas Corey | PERSON | 0.62+ |
same year | DATE | 0.59+ |
Cuban | LOCATION | 0.56+ |
Wide Association | TITLE | 0.55+ |
Jesus Storage | TITLE | 0.55+ |
R | ORGANIZATION | 0.5+ |
19 GSK | QUANTITY | 0.5+ |
Genome | ORGANIZATION | 0.48+ |
Doctor | TITLE | 0.45+ |
Pelosis | LOCATION | 0.42+ |
Day One Wrap - Nutanix .NEXTconf 2017 - #NEXTconf - #theCUBE
>> Announcer: Live from Washington DC, it's theCube, covering .NEXT conference. Brought to you by Nutanix. >> Welcome back to NEXT Conf, #NEXTConf. This is Nutanix's big customer event. This is theCube, the leader in live tech coverage. My name is Dave Vellante with Stu Miniman. This is our wrap, day one wrap, Stu. We had the practitioner day today. Interesting setup for Nutanix, they have the keynotes at the end of day one, which is kind of interesting, most companies have it at the beginning of the day. >> Dave, part of that was just logistically, this convention center, while it was kind of massive, there was another show wrapping up, so they had to shuffle things around and the advice I'd given them was, well, who do we put on? Well, put on some of the partners that we heard in announcements. >> Dave: Customers, baby. >> Give us users. I mean, Dave, more users, more users, more users, they deliver. >> Yeah, absolutely. I want to talk about that. Well, let's get right into it. I mean, every customer we talked to today had similar themes, right? Simplifying, getting rid of the non-differentiated heavy lifting, reducing the IT labor pain. All of them that we talked to were using Acropolis, selectively, they all loved VMware, but they were using Acropolis to make sure that there was a level playing field with regard to not only right workloads, but also, just sending a message to VMware that, hey, we have options. >> Yeah. Dave, the thing I loved about the customers, I think about the Scholastic interview we did. We went 10 minutes into the interview before we talked to the head of infrastructure about his infrastructure. We were talking about digital transformation, how they're helping children read and it's underneath, that invisible infrastructure happens to be from Nutanix, is helping them to do that. Same thing talked about with PXP, said it's not, oh, I could my infrastructure a little better, it's, how do I wow my IT staff to do what he called the fun stuff? That meant, I'm working on the analytics, I'm digging into Splunk and getting more value out of my data. That digital transformation is something that the customers here are embracing. The hybrid multicloud maybe not as much yet, so Nutanix is a little bit of ahead of their customers there, but right, there's some real good, customers that are embracing change and building that platform for the future, and Nutanix is a partner. >> The question I always have, because I always talk about, oh, everybody's doing the digital disruption, they've got to get rid of the banal infrastructure tasks, shift that to our digital transformation and analytics initiatives, data initiatives. Sounds good, but that's not easy, and the gentleman from PXP sort of underscored that. It took some time, we had to do some training. People, process, technology, it's the people and process stuff that is hard. That's something that's very interesting, I think, to me, Stu, is this shift that's going on. We talk about in true private cloud, $150 billion going out of heavy lifting, going into vendor R&D, true private cloud and public cloud. >> Stu: Right. >> True private cloud is the fastest growing sector. If you look at infrastructure as a service, software as a service, and true private cloud, those are the explosive growth areas. Virtually everything else in the enterprise is in flat or declining mode. >> Yeah, absolutely, Dave. Got to talk to a number of partners that are helping Nutanix expand where they're going. We're going to hear, Google's going to be in the keynote. Diane Greene, one we're looking forward to, the announcement today, Wall Street gave Nutanix a little bit of a bump, and gives them some added credibility into, really, why Nutanix should be considered a cloud partner. Actually, it was Scholastic said, that he really saw Google as thought leadership in containers and Kubernetes, and something they're starting to look at and therefore, gives him more reason, that when he deploys it, he's going to turn to Nutanix to help him look at it. Talk to Intel, talk to IBM, so some companies expanding what kind of applications are living on Nutanix. Some good thought leaders talking about, right, how IT can continue to be a sustained differentiation in the marketplace, something that I know is near and dear to your heart. >> Julia from Gartner was very guarded in her comments, I thought, excellent comments, but when we tried to sort of push her into the horses on the track conversation, she kind of stayed neutral. Okay, that's cool. But we like to riff independent thoughts on theCube. Nutanix, for a couple years now has been sort of pivoting away from so-called hyper converged infrastructure as everybody else moves to hyper converged infrastructure, and they're pivoting to cloud. The obvious next wave is that what the Fourier calls interclouding. Extending that control plane across multiple physical entities, whether it's public cloud, private cloud, on prem, off prem, legacy, etc., managing that. There's a lot of companies that are trying to do that. In your opinion, is that something that Nutanix should be doing, could be doing, will be doing? What are your thoughts on that? >> Yes, so Nutanix, if they built up the stack, we've said before, I think we said on the intro, Dave, Nutanix is looking to be like the next VMware. What does VMware need to do? VMware needs to know how they fit into that world that you just laid there. That's why Pat Gelsinger made a bold move, going to partner with Amazon. Nutanix has a little bit of a relationship with both AWS and Azure. Looks like they're goin to have a deeper relationship with Google to really expand what they're doing. They've made a few acquisitions in the market, it was calm.io was one that they acquired right before VMworld last year, and that is some of their really management layer, that control plane as to how they're going to look at managing in that multicloud world now. Does a customer turn to Nutanix? Do they turn to some of the stalwarts in the IT management space? Do they turn to the public clouds? Nutanix needs to prove this out, expand their road map, and get more customers excited. There's, I believe, we've said sometimes, it's a smaller show, it's about 4500 people is what they're expecting here at the show. This is a good size for a company that just went public. Not yet at a billion dollars, impressive, always good enthusiasm when we come to this show. Expecting lots, a high bar for what they should be delivering in the keynotes. >> All right, so good first day. We're coming at you tomorrow. We'll kick off with an assessment of the keynotes. Then tomorrow's a lot of Nutanix content. It's going to be great, we've got their executives on, some of their partners, we're going to have D-Rog, who's always a great guest. Very thoughtful. >> Stu: A couple more customers, too. >> Yeah, and more customers, so keep it right there. If you want us to ask questions of some of these guests, you can tweet us, he's @stu, I'm @dvellante. Check out siliconangle.com for all the news from this and other shows. Check out wikibon.com for all the research. Okay, that's it, we're out, we'll see you tomorrow. Thanks for watching, everybody. (electronic music)
SUMMARY :
Brought to you by Nutanix. Welcome back to NEXT Conf, #NEXTConf. so they had to shuffle things around I mean, Dave, more users, more users, more users, to make sure that there was a level playing field and building that platform for the future, shift that to our digital transformation Virtually everything else in the enterprise something that I know is near and dear to your heart. and they're pivoting to cloud. that control plane as to how they're going to look at It's going to be great, Check out siliconangle.com for all the news
SENTIMENT ANALYSIS :
ENTITIES
Entity | Category | Confidence |
---|---|---|
Dave Vellante | PERSON | 0.99+ |
Amazon | ORGANIZATION | 0.99+ |
Nutanix | ORGANIZATION | 0.99+ |
Diane Greene | PERSON | 0.99+ |
Dave | PERSON | 0.99+ |
ORGANIZATION | 0.99+ | |
IBM | ORGANIZATION | 0.99+ |
Pat Gelsinger | PERSON | 0.99+ |
$150 billion | QUANTITY | 0.99+ |
Washington DC | LOCATION | 0.99+ |
Stu Miniman | PERSON | 0.99+ |
10 minutes | QUANTITY | 0.99+ |
last year | DATE | 0.99+ |
Intel | ORGANIZATION | 0.99+ |
AWS | ORGANIZATION | 0.99+ |
tomorrow | DATE | 0.99+ |
@dvellante | PERSON | 0.99+ |
Stu | PERSON | 0.99+ |
today | DATE | 0.99+ |
PXP | ORGANIZATION | 0.99+ |
siliconangle.com | OTHER | 0.99+ |
Wall Street | ORGANIZATION | 0.98+ |
Acropolis | ORGANIZATION | 0.98+ |
both | QUANTITY | 0.98+ |
VMworld | ORGANIZATION | 0.98+ |
first day | QUANTITY | 0.98+ |
VMware | ORGANIZATION | 0.97+ |
@stu | PERSON | 0.97+ |
Julia | PERSON | 0.95+ |
billion dollars | QUANTITY | 0.94+ |
Gartner | ORGANIZATION | 0.93+ |
about 4500 people | QUANTITY | 0.93+ |
#NEXTconf | EVENT | 0.88+ |
#NEXTConf | EVENT | 0.87+ |
day one | QUANTITY | 0.84+ |
wave | EVENT | 0.84+ |
D-Rog | PERSON | 0.82+ |
Day One | QUANTITY | 0.82+ |
calm.io | ORGANIZATION | 0.81+ |
Nutanix .NEXTconf | EVENT | 0.77+ |
NEXT Conf | EVENT | 0.71+ |
Kubernetes | TITLE | 0.69+ |
Azure | ORGANIZATION | 0.68+ |
one | QUANTITY | 0.65+ |
couple years | QUANTITY | 0.62+ |
couple | QUANTITY | 0.61+ |
wikibon.com | OTHER | 0.56+ |
2017 | DATE | 0.54+ |
Scholastic | ORGANIZATION | 0.52+ |
.NEXT | EVENT | 0.49+ |
Scholastic | TITLE | 0.44+ |
theCube | ORGANIZATION | 0.43+ |
Fourier | TITLE | 0.38+ |
Splunk | TITLE | 0.38+ |